Meh, easy to say with hindsight. This story still has more to play out and I think in the next few months, the buyback will prove to have been astute.
I am more concerned about the tardiness in releasing the Marampa scoping report. The uncertainty is probably what is dragging the sp down and thus making the bb look ill conceived.
I am still happy with my substantially overweight position. Next week I will be adding all the assets from the copperco transaction (including the listed ones) to see what sort of a return CFE has made on these assets. I suspect it will almost be equal to the mkt cap of CFE.
The business model is very profitable, the market doesn't like it because it is also uncertain.
- Forums
- ASX - By Stock
- CLE
- buyback a failure
buyback a failure, page-3
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLE (ASX) to my watchlist
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.47M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $95 | 95K |
Featured News
CLE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online